Topline results reported from phase II study of REL-1017 in treatment-resistant depression Oct. 16, 2019
Cyteir Therapeutics secures funding and doses first patient in phase I/II study of CYT-851 Oct. 16, 2019
Competition between HuR and miR-330 modulates STAT3 expression promoting muscle wasting in cachexia Oct. 16, 2019
First clinical trial of an extracellular matrix hydrogel in post-myocardial infarction patients Oct. 16, 2019
New anti-CD30 ADC shows promising preclinical profile for CD30-positive hematological malignancies Oct. 16, 2019
RSS